Faron Pharmaceuticals Oy (AIM: FARN)
207.00
-8.00 (-3.72%)
Sep 11, 2024, 4:12 PM GMT+1
Faron Pharmaceuticals Oy Statistics
Total Valuation
Faron Pharmaceuticals Oy has a market cap or net worth of GBP 216.57 million. The enterprise value is 201.94 million.
Market Cap | 216.57M |
Enterprise Value | 201.94M |
Important Dates
The next estimated earnings date is Wednesday, November 27, 2024.
Earnings Date | Nov 27, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Faron Pharmaceuticals Oy has 104.62 million shares outstanding. The number of shares has increased by 14.45% in one year.
Shares Outstanding | 104.62M |
Shares Change (YoY) | +14.45% |
Shares Change (QoQ) | +4.96% |
Owned by Insiders (%) | 24.28% |
Owned by Institutions (%) | 7.38% |
Float | 73.58M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 185.25 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -7.54 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.45, with a Debt / Equity ratio of 922.55.
Current Ratio | 1.45 |
Quick Ratio | 1.28 |
Debt / Equity | 922.55 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -4.83 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -70.00% |
Return on Capital (ROIC) | -186.82% |
Revenue Per Employee | n/a |
Profits Per Employee | -788,198 |
Employee Count | 34 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.85% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -16.85% |
50-Day Moving Average | 163.28 |
200-Day Moving Average | 167.42 |
Relative Strength Index (RSI) | 62.04 |
Average Volume (20 Days) | 37,861 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -22.93M |
Pretax Income | -26.76M |
Net Income | -26.80M |
EBITDA | -22.78M |
EBIT | -22.93M |
Earnings Per Share (EPS) | -0.39 |
Balance Sheet
The company has 25.42 million in cash and 10.79 million in debt, giving a net cash position of 14.63 million or 0.14 per share.
Cash & Cash Equivalents | 25.42M |
Total Debt | 10.79M |
Net Cash | 14.63M |
Net Cash Per Share | 0.14 |
Equity (Book Value) | 1.17M |
Book Value Per Share | 0.01 |
Working Capital | 8.88M |
Cash Flow
Operating Cash Flow | -17.09M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Faron Pharmaceuticals Oy does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -14.45% |
Shareholder Yield | -14.45% |
Earnings Yield | -18.82% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |